Shah Nimish P
SEC insider (Form 3/4/5 filer). CIK 0001698082. Director at Korsana Biosciences, Inc. (KRSA) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in WALTHAM, MA.
Companies Shah Nimish P has filed insider reports for
- Korsana Biosciences, Inc. (KRSA): Director
- Apogee Therapeutics, Inc. (APGE): Director
Shah Nimish P
CIK: 0001698082
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 9, 2026KRSA
Korsana Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
48.4K shares- - Sep 3, 2026APGE
Apogee Therapeutics, Inc.
DispositionIndirect1.8M shares at avg. $135.11$236.4M - Jun 9, 2026APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.7K shares- - Oct 10, 2025APGE
Apogee Therapeutics, Inc.
PurchaseIndirectPre-Funded Warrants (Right to Buy)
365.9K shares at avg. $41.00- - Jun 17, 2025APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  KRSA Korsana Biosciences, Inc. | Award Stock Option (Right to Buy) | 48,445 | - | - | Direct |
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition | 1,750,000 | $135.11 | $236,442,500 | Indirect |
| Jun 9, 2026 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,657 | - | - | Direct |
| Oct 10, 2025 | APGE Apogee Therapeutics, Inc. | Purchase Pre-Funded Warrants (Right to Buy) | 365,853 | $41.00 | - | Indirect |
| Jun 17, 2025 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 14,461 | - | - | Direct |
1-5 of 5 transactions